Literature DB >> 6196431

Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

J S Gaston, A B Rickinson, M A Epstein.   

Abstract

Epstein-Barr (EB) virus-specific cytotoxic T cells, prepared from virus-immune donors by reactivation in vitro and maintained thereafter as IL-2-dependent T cell lines, have been tested against large panels of EB virus-transformed lymphoblastoid cell lines of known HLA type. Whilst the pattern of lysis of the majority of targets was always consistent with HLA-A and HLA-B antigen restriction of effector function, in several cases it was noticed that certain HLA-mismatched targets were also reproducibly lysed. When this "anomalous" lysis was investigated in detail, it was found to be directed against allodeterminants on class I HLA antigens; thus, mitogen-stimulated as well as EB virus-transformed lymphoblasts from the relevant target cell donors were sensitive to the killing, and in each case the lysis could be specifically blocked by monoclonal antibodies to class I HLA antigens. In one example the target for this alloreactive lysis could be identified as a single serologically defined antigen, HLA-Bw57, while in another example lysis was directed against a "public" epitope common to HLA-Bw35, -Bw62, and a subset of -B12 antigens. Both cold target inhibition experiments and limiting dilution analysis strongly suggested that this alloreactive lysis was being mediated by the same effector T cells that recognize EB viral antigens in the context of self-HLA. This is the first demonstration in man that alloreactive responses can be derived from within the antigen-specific, self MHC-restricted T cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196431      PMCID: PMC2187177          DOI: 10.1084/jem.158.6.1804

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells.

Authors:  R Finberg; S J Burakoff; H Cantor; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

Review 3.  HLA-A, -B and -C antigens, their serology and cross-reaction.

Authors:  V C Joysey; E Wolf
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

4.  Human cell-mediated cytotoxicity against modified target cells is restricted by HLA.

Authors:  E Dickmeiss; B Soeberg; A Svejgaard
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

5.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.

Authors:  D J Moss; L E Wallace; A B Rickinson; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

6.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.

Authors:  L E Wallace; D J Moss; A B Rickinson; A J McMichael; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

7.  Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A.

Authors:  H S Teh; R A Phillips; R G Miller
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

8.  The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens.

Authors:  S J Burakoff; R Finberg; L Glimcher; F Lemonnier; B Benacerraf; H Cantor
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus.

Authors:  A Müllbacher; R V Blanden; M Brenan
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes.

Authors:  T J Braciale; M E Andrew; V L Braciale
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  15 in total

1.  In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.

Authors:  G Strang; A B Rickinson
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.

Authors:  F M Gotch; C Kelly; S A Ellis; L Wallace; A B Rickinson; J van der Poel; M J Crumpton; A J McMichael
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 3.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  Dk-restricted antiinfluenza cytotoxic T-cell clone loses one of its two alloreactivities.

Authors:  D C Wraith
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  HLA-B27, a dominant restricting element in antiviral responses?

Authors:  E Gomard; M Sitbon; A Toubert; B Bègue; J P Lévy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.

Authors:  J S Gaston; L E Wallace; A B Rickinson; M A Epstein; D Pious
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

Review 9.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

Review 10.  TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.

Authors:  L J D'Orsogna; D L Roelen; I I N Doxiadis; F H J Claas
Journal:  Immunogenetics       Date:  2011-12-03       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.